Negative regulation of T cell apoptotic process

pathway activity — cross-omics
GO:0070233Cross-omicsPROTEIN-MS → DRUGCellPairwise association · TCGA cohorts

Across TCGA cell cohorts, RNA activity of the Negative regulation of T cell apoptotic process pathway is significantly associated with the drug response of multiple features, with the BLOOD_Lymphoma cohort showing a particularly strong set of associations.

The most reproducible pathway-associated features across cancer lineages are CAP-232, PLK_6522, and Venetoclax, each associated with the pathway in up to 3 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The box plot shows the strongest association, CAP-232 grouped by Negative regulation of T cell apoptotic process-low versus -high activity in BLOOD_Lymphoma.

Pathway-associated features by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner featureX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_LymphomaCAP-232 →-0.679-0.651.023.01233
OESOPHAGUSPLK_6522 →-0.696-0.817.012.01432
OESOPHAGUSVenetoclax →-0.478-1.186<.001.00932
OESOPHAGUSDactinomycin →-0.426-0.739.035.01232
BLOOD_LymphomaIAP_7638 →+0.537+0.519.012.01832
BLOOD_LymphomaMG-132 →+0.739+0.687<.001.00732
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

CAP-232 by Negative regulation of T cell apoptotic process activity — BLOOD_Lymphoma

Box plot of CAP-232 in Negative regulation of T cell apoptotic process-low vs -high samples in BLOOD_Lymphoma.

Explore this box plot interactively →

Exploration